ers. Now we've shown that mutations in the DICER1 gene are directly linked to the development of PPB."
"For years our large collection of cases of PPB and families has revealed the strong genetic component of this disease," said Jack Priest, M.D., research director of the International PPB Registry in Minnesota. "We are thrilled that our colleagues Drs. Hill and Goodfellow uncovered an important mutation and have begun to understand the cellular mix-up which results in malignancy." Current studies show around 40 percent of PPB cases occur in families with a history of the disease or certain other childhood cancers. In contrast, most pediatric cancers occur sporadically, without any familial patterns. This led scientists and doctors to suspect that the cancers were caused by an inherited genetic abnormality. To uncover the role of DICER1, the research team studied the genetic makeup of 11 extended families with two or more members having PPB or related childhood cancers.
The scientists say that finding this variant form of a gene in some PPB families is a first step to understanding why PPB and other conditions may occur in some families. But, because only a small number of families were studied it isn't known whether DICER1 mutations explain all PPB cases, and much more needs to be learned before this information can be directly helpful to PPB families.
In collaboration with Drs. Hill and Goodfellow, and with Louis P Dehner, M.D., of Washington University St. Louis, who first described PPB in 1988, the International PPB Registry in Minnesota has collected and analyzed PPB cases from around the world for more than 20 years. More than 260 confirmed cases are being followed. The Registry is funded by Minneapolis/St. Paul-area foundations and is the only organization in the world focused exclusively on PPB.
Hill DA, Ivanovich J, Priest JR, Gurnett CA, Dehner LP, Desruisseau D, Jarzembowski
'/>"/>
SOURCE Children's Hospitals and Clinics of Minnesota; Washington University School of Medicine in St. Louis; Children's National Medical Center in Washington, D.C. Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 Related medicine technology :1.
Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity2.
Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity3.
Genetics Determine Optimal Drug Dose of Common Anticoagulant4.
CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue5.
Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Review of its Phase 1/2 Trial of tgAAC94 for Rheumatoid Arthritis6.
Genetic Differences Predict Anti-Inflammatory Benefits From Nutritional Products7.
454 Sequencing(TM) in Science Today: Researchers Uncover a Genetic Basis for Different Social Behaviors in Wasps8.
deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack9.
Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers10.
American Fertility Association Calls for Expanded Research to Advance New Technology to Screen Embryos for Genetic Abnormalities11.
Groundbreaking Study Proves Personalized Diet Based on Genetics Leads to Significant Advances in Long Term Weight Management and Blood Glucose Levels